Robert S. Baltimore
Abstract
Respiratory syncytial virus immune globulin (RSVIG) is a new product approved for prevention of RSV infection in infants with chronic lung disease or
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Respiratory syncytial virus immune globulin (RSVIG) is a new product approved for prevention of RSV infection in infants with chronic lung disease or
Key concepts: Medicine, Immune system, Immunology, Virology